Enanta Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ENTA Nasdaq 2834 www.enanta.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Enanta Pharmaceuticals, Inc.

Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates - May 8th, 2025 10:20 pm
Enanta Pharmaceuticals, Inc. (ENTA): The Best Breakout Stock to Buy According to Analysts - May 5th, 2025 9:53 pm
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025 - Apr 8th, 2025 11:00 am
Enanta Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference - Mar 17th, 2025 11:00 am
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium - Mar 12th, 2025 11:00 am
With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns - Feb 15th, 2025 12:21 pm
President of Enanta Pharmaceuticals Picks Up 5.9% More Stock - Feb 15th, 2025 12:14 pm
Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade - Feb 14th, 2025 5:00 pm
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates - Feb 10th, 2025 10:10 pm
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot - Feb 10th, 2025 9:11 pm
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024 - Feb 10th, 2025 9:01 pm
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial - Jan 30th, 2025 1:03 pm
Recursion Pharmaceuticals (RXRX) Moves 8.9% Higher: Will This Strength Last? - Jan 23rd, 2025 2:45 pm
Enanta Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2025 12:00 pm
Sector Update: Health Care Stocks Mixed Tuesday Afternoon - Dec 24th, 2024 5:47 pm
Top Midday Decliners - Dec 24th, 2024 5:38 pm
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit - Dec 24th, 2024 12:00 pm
Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? - Dec 23rd, 2024 2:43 pm
Enanta’s zelicapavir shows promise in paediatric respiratory syncytial virus trial - Dec 10th, 2024 5:34 pm
Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) - Dec 9th, 2024 11:30 am